Hemochromatosis and iron-overload screening in a racially diverse population

New England Journal of Medicine

Volumn 352, Issue 17, 2005, Pages 1769-1778

  Adams, Paul C ^a   Reboussin, David M ^b   Barton, James C ^c   McLaren, Christine E ^d   Eckfeldt, John H ^e   McLaren, Gordon D ^d,f   Dawkins, Fitzroy W ^g   Acton, Ronald T ^h   Harris, Emily L ⁱ   Gordeuk, Victor R ^g   Leiendecker Foster, Catherine ^e   Speechley, Mark ^j   Snively, Beverly M ^b   Holup, Joan L ⁱ   Thomson, Elizabeth ^k   Sholinsky, Phyliss ^l  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c SOUTHERN IRON DISORDERS CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^g HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

ⁱ KAISER PERMANENTE   (United States)

^j UNIVERSITY OF WESTERN ONTARIO   (Canada)

^k NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^l NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON;

ADULT; AFRICAN AMERICAN; AGED; AMERICAN INDIAN; ARTICLE; ASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC AND RACIAL GROUPS; EUROPEAN AMERICAN; FEMALE; FERRITIN BLOOD LEVEL; GENETIC ASSOCIATION; GENETIC SCREENING; GENOTYPE; HEMOCHROMATOSIS; HEREDITY; HISPANIC; HOMOZYGOSITY; HUMAN; IRON OVERLOAD; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MUTATION; PACIFIC ISLANDER; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SCREENING; WILD TYPE;

ARTHRITIS; DIABETES COMPLICATIONS; FEMALE; FERRITINS; GENE FREQUENCY; GENOTYPE; HEART DISEASES; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; IRON; IRON OVERLOAD; LIVER DISEASES; LOGISTIC MODELS; MALE; MEMBRANE PROTEINS; MUTATION; PHENOTYPE; SEX DISTRIBUTION; TRANSFERRIN; UNITED STATES;

EID: 20244372858     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa041534     Document Type: Article

References (32)

1. Bacon BR. Hemochromatosis: diagnosis and management. Gastroenterology 2001;120:718-25.
2. Pietrangelo A. Hereditary hemochromatosis - a new look at an old disease. N Engl J Med 2004;350:2383-97.
3. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-19.
4. Gordeuk VR, Boyd RD, Brittenham GM. Dietary iron overload persists in rural sub-Saharan Africa. Lancet 1986;1:1310-3.
5. Gordeuk V, Caleffi A, Corradini E, et al. Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene. Blood Cells Mol Dis 2003;31:299-304.
6. Barton JC, Acton RT, Rivers CA, et al. Genotypic and phenotypic heterogeneity of African Americans with primary iron overload. Blood Cells Mol Dis 2003;31: 310-9.
7. Eason RJ, Adams PC, Aston CE, Searle J. Familial iron overload with possible autosomal dominant inheritance. Aust N Z J Med 1990;20:226-30.
8. Oliver M, Scully L, Guiraudon C, Adams PC. Non-HLA-linked hemochromatosis in a Chinese woman. Dig Dis Sci 1995;40:1589-91.
9. Kng C, Ng FH, Ng WF, et al. A Chinese patient with non-HFE linked iron overload. J Clin Gastroenterol 2001;33:69-71.
10. McLaren CE, Barton JC, Adams PC, et al. Hemochromatosis and Iron Overload Screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults. Am J Med Sci 2003;325:53-62.
11. Weir BS. Genetic data analysis II: methods for discrete population genetic data. Sunderland, Mass.: Sinauer, 1996.
12. Cox DR, Hinkley DV. Theoretical statistics. London: Chapman & Hall, 1974.
13. Beaton M, Guyader D, Deugnier Y, Moirand R, Chakrabarti S, Adams P. Non-invasive prediction of cirrhosis in C282Y-linked hemochromatosis. Hepatology 2002; 36:673-8.
14. Morrison ED, Brandhagen DJ, Phatak PD, et al. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med 2003;138:627-33. [Erratum, Ann Intern Med 2003;139;235.]
15. Ioannou GN, Dominitz JA, Weiss NS, Heagerty PJ, Kowdley KV. The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia. Gastroenterology 2004;126: 1293-301.
16. Asberg A, Hveem K, Thorstensen K, et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001;36:1108-15.
17. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of the 845G to A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-8.
18. Steinberg KK, Cogswell ME, Chang JC, et al. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA 2001;285:2216-22.
19. Lucotte G, Dieterlen F. A European allele map of the C282Y mutation of hemochromatosis: Celtic versus Viking origin of the mutation? Blood Cells Mol Dis 2003;31: 262-7.
20. Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, Rochette J, Robson KJ. Geography of HFE C282Y and H63D mutations. Genet Test 2000;4:183-98.
21. Rochette J, Pointon JJ, Fisher CA, et al. Multicentric origin of hemochromatosis gene (HFE) mutations. Am J Hum Genet 1999;64:1056-62. [Erratum, Am J Hum Genet 1999;64:1491.]
22. Adams PC, Agnew S. Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences among homozygous siblings. Hepatology 1996;23: 724-7.
23. Bacon BR, Olynyk JK, Brunt EM, Britton RS, Wolff RK. HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med 1999;130:953-62.
24. Adams PC, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology 1997;25:162-6.
25. Yamashita C, Adams PC. Natural history of the C282Y homozygote for the hemochromatosis gene (HFE) with a normal serum ferritin level. Clin Gastroenterol Hepatol 2003;1:388-91.
26. Olynyk JK, Hagan SE, Cullen DJ, Beilby J, Whittall DE. Evolution of untreated hereditary hemochromatosis in the Busselton population: a 17-year study. Mayo Clin Proc 2004;79:309-13.
27. Andersen RV, Tybjaerg-Hansen A, Appleyard M, Birgens H, Nordestgaard BG. Hemochromatosis mutations in the general population: iron overload progression rate. Blood 2004;103:2914-9.
28. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999; 341:718-24.
29. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30:1356-62.
30. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992;102:2108-13.
31. Riggio O, Montagnese F, Fiore P, et al. Iron overload in patients with chronic viral hepatitis: how common is it? Am J Gastroenterol 1997;92:1298-301.
32. Tung BY, Emond MJ, Bronner MP, Raaka SD, Cotler SJ, Kowdley KV. Hepatitis C, iron status, and disease severity: relationship with HFE mutations. Gastroenterology 2003;124:318-26.